Tesco plc (LON:TSCO) has announced its preliminary results for 2021/22. Performance highlights1,2: 2021/22 2020/213 Change at actual rate Change at constant rate Group sales (exc. VAT, exc. fuel)4 £54,768m £53,445m..
GlaxoSmithKline plc (LON/NYSE:GSK) and Sierra Oncology, Inc (Nasdaq:SRRA) has announced that the companies have entered into an agreement under which GSK will acquire Sierra Oncology, a California-based, late-stage biopharmaceutical company..
Cambridge Cognition Holdings plc (LON:COG) CEO Matthew Stork and new CFO Stephen Symonds join DirectorsTalk Interviews to discuss preliminary results for the year ended 31st December 2021. Stephen having joined..
Structured products income fund Volta Finance Ltd (LON:VTA) has provided its AXA IM monthly report for March. The full report can be viewed or downloaded here. PERFORMANCE and PORTFOLIO ACTIVITY March..
AMTE Power Plc (LON:AMTE), the developer and manufacturer of lithium-ion and sodium-ion battery cells for specialist market, has announced that it has partnered with Sprint Power and Eltrium to accelerate..
Egdon Resources plc (LON:EDR) has this morning advisd that further to the announcement of 25 January 2022, it has submitted an appeal against the refusal of planning permission by Lincolnshire..
itim Group plc (LON:ITIM), a SaaS based technology company that enables store-based retailers to optimise their businesses to improve financial performance, has announced three new customer wins and extensions of..
Billington Holdings Plc (LON: BILN), one of the UK’s leading structural steel and construction safety solutions specialists, has provided the following trading update ahead of the release of the Company’s..
Union Jack Oil plc (LON:UJO) a UK focused onshore hydrocarbon production, development and exploration company, has advised that further to the announcement of 25 January 2022, the Operator of PEDL253,..
Open Orphan plc (LON:ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, noted the announcement..
